Central Pharmaceuticals Ratios and Metrics

Market cap in millions BDT. Fiscal year is July - June.

Millions BDT. Fiscal year is Jul - Jun.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 15, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Market Capitalization	1,114	1,246	2,168	1,486	1,569	1,581
Market Cap Growth	-15.45%	-42.54%	45.97%	-5.34%	-0.76%	-0.75%
Enterprise Value	1,381	1,513	2,454	1,752	1,818	1,803
Last Close Price	9.30	10.40	18.10	12.40	13.10	13.20
PS Ratio	30.87	37.69	73.26	50.65	60.37	10.67
PB Ratio	1.36	1.51	2.57	2.22	2.20	2.02
P/TBV Ratio	1.36	1.51	2.57	2.22	2.20	2.02
P/FCF Ratio	-	-	731.27	-	-	-
P/OCF Ratio	-	-	731.27	-	-	880.40
EV/Sales Ratio	38.27	45.77	82.90	59.75	69.92	12.17
EV/EBITDA Ratio	-	-	-	-	-	45.42
EV/EBIT Ratio	-	-	-	-	-	264.59
EV/FCF Ratio	-	-	827.53	-	-	-
Debt / Equity Ratio	0.33	0.33	0.32	0.40	0.38	0.32
Debt / EBITDA Ratio	94.91	-	-	-	-	6.33
Debt / FCF Ratio	-	-	90.64	-	-	-
Net Debt / Equity Ratio	0.33	0.33	0.32	0.40	0.37	0.32
Net Debt / EBITDA Ratio	94.47	-246.49	-11.01	-12.66	-11.31	6.26
Net Debt / FCF Ratio	-10975.06	-515.45	90.05	-819.93	-238.46	-52.00
Asset Turnover	-	0.02	0.02	0.02	0.02	0.11
Inventory Turnover	-	2.22	2.55	1.90	1.26	2.06
Quick Ratio	0.20	0.20	0.23	0.25	0.25	0.26
Current Ratio	1.06	1.10	1.14	1.18	1.25	1.37
Return on Equity (ROE)	-	-2.63%	-5.60%	-6.35%	-9.12%	-1.08%
Return on Assets (ROA)	-	-0.99%	-1.74%	-2.32%	-2.49%	0.31%
Return on Invested Capital (ROIC)	-2.16%	-2.06%	-3.68%	-4.99%	-5.30%	0.67%
Return on Capital Employed (ROCE)	-2.20%	-2.10%	-3.40%	-5.10%	-5.40%	0.60%
Earnings Yield	-1.95%	-1.76%	-1.96%	-2.96%	-4.35%	-0.54%
FCF Yield	-	-0.04%	0.14%	-0.02%	-0.07%	-0.30%